Skip to main content
logo
Bacil Pharma Limited (BOM:524516)
India flag India · Delayed Price · Currency is INR
23.38
+0.95 (4.24%)
At close: Sep 22, 2026

Bacil Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
322685610863234
Market Cap Growth
-41.04%12.33%607.73%166.97%-4.36%83.65%
Enterprise Value
316669610832833
Last Close Price
22.4347.7342.4914.635.485.73

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
36.9944.04150.92---
PB Ratio
1.302.762.407.102.942.76
P/TBV Ratio
1.302.762.407.102.942.76
P/FCF Ratio
45.2496.27152.16---
P/OCF Ratio
45.2496.27152.16---

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/FCF Ratio
44.4494.03152.28---

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
--0.010.080.020.03
Debt / FCF Ratio
--0.41---
Net Debt / Equity Ratio
-0.02-0.02-0.110.05-0.18-0.22
Net Debt / EBITDA Ratio
-2.3310.67-0.301.121.76
Net Debt / FCF Ratio
--0.80-6.72-19.641.350.07
Quick Ratio
-0.6817.200.377.876.49
Current Ratio
-0.6817.210.468.196.69
Return on Equity (ROE)
-6.19%3.03%-5.11%-8.77%-295.12%
Return on Assets (ROA)
--0.58%-1.18%-9.62%-9.37%-3.70%
Return on Invested Capital (ROIC)
-0.66%-1.04%-2.09%-17.40%-19.41%-13.92%
Return on Capital Employed (ROCE)
--1.00%-1.00%-15.60%-16.30%-13.00%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
2.70%2.27%0.66%-0.69%-3.16%-114.37%
FCF Yield
2.21%1.04%0.66%-0.03%-4.57%-118.79%
Buyback Yield / Dilution
--121.94%-6.92%1.47%-1.71%-0.99%